Strengthening the global response to climate change and infectious disease threats Climate change is emerging as an important driver of disease incidence, and a wait and see approach invites unnecessary risk. Governments, funders, researchers, and practitioners must act now.
A global survey of potential acceptance of a COVID-19 vaccine This study surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 61.4% reported that they would accept their employer’s recommendation to do so. Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer’s advice to do so.
Emerging Diseases: 2020 Article Collection Take a look at a selection of recently published articles in the Royal Society of Tropical Medicine and Hygiene (RSHTM) looking at emerging diseases in 2020.
Coronavirus Pandemic - Latest Publications LSHTM Read the latest publications relating to COVID-19 from London School of Hygiene and Tropical Medicine (LSHTM) experts who are involved in many different aspects of COVID-19 research, as well as providing guidance to those responding around the globe every day.
The role of gender inclusive leadership during the COVID-19 pandemic to support vulnerable populations in conflict settings Lessons learned from previous disease outbreaks in conflict settings should be harnessed to mitigate gendered impacts of COVID-19 on populations in conflict-affected countries. Increased diversity and gender-balanced leadership is an essential requirement in key committees and in multilateral organisations in developing pandemic preparedness and responses.
What are the concerns for COVID-19 in Africa? Here John Nkengasong and Wessam Mankoula discuss the challenges facing the continent.
What are the gendered impacts of the outbreak? This recent article discusses the apparent increased risk of serious disease in men, and early evidence from China on the risks of adverse psychological effects for many women providing frontline care.
There has been much attention given to older people and those with co-existing health problems, but are there other groups that need consideration? Here Richard Armitage and Laura Nellums from the University of Nottingham describe how the COVID-19 response must be disability inclusive.
What are the treatments for COVID-19? This article provides preliminary data from a phase 3 randomised controlled trial of Remdesivir compared to placebo suggesting that time to recovery was shorter in adults hospitalised with the infection.